On Monday, Nov. 2, Neuros Medical Inc. announced it has raised , in an . The Willoughby Hills-based neuromodulation company is developing a patented treatment of chronic, post-amputation pain with a high-frequency electrical signal.
The technology for the therapy was created by and , staff scientists at MetroHealth Medical Center and professors at ÐÇ¿Õ´«Ã½, who have been researching this since 2000.
an electrode placed around a peripheral nerve and an implantable pulse generator (IPG). A high-frequency electrical signal is delivered to sensory nerves in the peripheral nervous system to block the pain signal. Results from a pilot trial in 2013 showed pain reduction at an average of 83%.
Kilgore and Bhadra were awarded a from National Institute of Neurological Disorders and Stroke and in 2015.